BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
BCAX
92 hedge funds and large institutions have $633M invested in Bicara Therapeutics Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+8
Holders Change %
+9.52%
% of All Funds
1.25%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
28
Increased
26
Reduced
18
Closed
19
Calls
$1K
Puts
$2K
Net Calls
-$1K
Net Calls Change
-$23K
Top Buyers
| 1 |
VPC
Vestal Point Capital
New York
|
+$26.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.5M |
| 3 |
Morgan Stanley
New York
|
+$9.76M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.43M |
